From: Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients
BARC Type
Observation Group (n = 43)
Control Group (n = 42)
χ2
P-value
Type 3
0
2 (4.76%)
Fisher’s exact
0.121
Type 2
1 (2.33%)
4 (9.52%)
1.872
0.154
Type 1
0.498
Total
2 (4.65%)
6 (14.29%)
4.242
0.039